Differential Impacts on Billed Charges Versus Patient Routing
Theoretical models of healthcare consumerism presume that public disclosure of clinical prices equips patients to act as rational economic agents who evaluate costs and select higher-value providers ("Price and Quality Transparency: The Dawn of Medical Shopping"). This framework suggests that eliminating price opacity fosters competitive shopping, prompting individuals to seek lower-priced facilities even if it requires traveling greater distances for elective inpatient procedures ("Consumerism Meets Healthcare Through Price Transparency"). However, empirical analysis reveals a substantial divergence between theoretical market mechanisms and practical consumer responses. Evidence evaluating state-level price transparency tools in Arizona and Iowa demonstrates that public disclosure mandates generate little to no measurable impact on the distance patients travel to receive care ("Effects of Public Price Transparency Tools on Shopping for Health Care"). Instead of activating consumer-driven mobility across geographic areas, price transparency primarily exerts direct institutional pressure on providers, causing billed charges to decline upon policy rollout and rise following regulatory obsolescence ("Effects of Public Price Transparency Tools on Shopping for Health Care"). This disconnect persists even for relatively homogeneous inpatient treatments, indicating that institutional and financial factors—such as Medicaid expansion, insurance status, facility openings, and facility closures—drive patient routing far more effectively than public price listings ("Effects of Public Price Transparency Tools on Shopping for Health Care"). Consequently, while transparency mandates influence provider charge structures, they fail to transform patients into active shoppers without targeted reforms addressing underlying consumer incentives.